Company profile
The company is a high-tech biopharmaceutical enterprise in Hubei Province, which takes the national first-class new drug Jinlujie-mouse nerve growth factor for injection as the leading product and aims to establish a first-class biological innovation drug enterprise. the main business is the research and development, production and sales of biological products (freeze-dried injection of mouse nerve growth factor for injection, freeze-dried powder of anti-hepatitis B transfer factor for injection), thrombin and other chemicals.
The highlight of the company
(1) the factory area of the company covers an area of 138000 square meters, the existing construction area is more than 20, 000 square meters, and the production plant which meets the national GMP certification standard is more than 10000 square meters. The company has unique product advantages. The leading product Jinlujie-Mouse nerve growth Factor for injection is a new biological product in the country, which is the first drug for nerve injury diseases approved by the government in the world. The project originated from the 1986 Nobel Prize in Physiology and Medicine. The company successfully transformed it into industrial products and won the key support of the National Torch Plan and the National Innovation Fund Program. The company also has more than 20 kinds of products, such as hepatitis B therapeutic drug Organ peptide, hemostatic thrombin and so on.
(2) Jin Lujie, the company's leading product, has been produced and sold since it was put on the market. After years of marketing, the market scale has expanded rapidly. Jin Lujie trademark has won the title of famous trademark in Hubei Province. Jin Lujie products have established a good reputation and brand awareness between doctors and patients. Brand advantages help the company's Jinlujie products to maintain its market leading position.
(3) the company is a high-tech biopharmaceutical enterprise in Hubei Province, with strong technical R & D strength. After years of R & D team building, technology platform construction and R & D projects, the company basically established several technical platforms, such as protein separation and purification, virus inactivation / removal, genetic engineering bacteria / cells construction and cytological activity detection of biological products, and has genetic engineering pilot production (E. coli expression system). Two pilot test platforms of 30-liter, 150-liter and 500-liter fermentor and freeze-dried powder injection preparation pilot production (0.3 square meter freeze dryer) It has "protein separation and purification technology for extracting, separating and purifying single component target protein from complex and multi-component tissues", "virus inactivation / removal technology for products extracted from biological tissues and eukaryotic expression products" and "recombinant protein engineering strain or engineering cell strain construction technology" and other R & D technology level.
